Global Pharmaceuticals & Biotech Strong Balance Sheet Stocks

Perseus Proteomics

Market Cap: JP¥4.7b

A drug discovery biotech venture company, develops antibody drugs against cancer and other diseases in Japan.

Birzeit Pharmaceuticals

Market Cap: US$139.9m

Manufactures and trades in various medicines in the Palestinian Authority.

Northeast Pharmaceutical Group

Market Cap: CN¥7.6b

Engages in chemical pharmaceuticals preparations, pharmaceutical business, pharmaceutical engineering, biomedicine, and other businesses in China.

Beijing Tongrentang

Market Cap: CN¥46.9b

Engages in the research, production, distribution, and sale of Chinese patent medicines in China and internationally.

Par Drugs and Chemicals

Market Cap: ₹1.3b

Develops, manufactures, and sells active pharmaceutical ingredients (APIs) and fine chemicals in India.

Fermenta Biotech

Market Cap: ₹9.3b

Manufactures and markets chemicals, bulk drugs, and enzymes in India, Europe, the United States, and internationally.

Patrys

Market Cap: AU$9.2m

Develops and commercializes antibody technologies for the treatment of cancer in Australia.

Zhejiang Xianju PharmaceuticalLtd

Market Cap: CN¥9.7b

Manufactures and sells steroids and hormones worldwide.

Xiamen Amoytop Biotech

Market Cap: CN¥33.4b

Engages in research, development, production, and sale of recombinant protein drugs in China.

Zhejiang Sunflower Great Health

Market Cap: CN¥10.1b

Zhejiang Sunflower Great Health Co., Ltd.

Korean Drug

Market Cap: ₩48.9b

Manufactures and sells medicines for treating various diseases in South Korea.

Zhejiang Tailin BioEngineeringLtd

Market Cap: CN¥4.1b

Offers life science system solutions in China.

Zhangzhou Pientzehuang Pharmaceutical

Market Cap: CN¥119.0b

Engages in the manufacture and sale of Chinese medicines under the Pien Tze Huang brand in China and internationally.

PanGen Biotech

Market Cap: ₩81.2b

Operates as a biologics company in South Korea.

Cell Biotech

Market Cap: ₩84.9b

A biotechnology company, develops lactic acid bacteria products in South Korea and internationally.

Pharos iBio

Market Cap: ₩71.5b

Develops treatments for rare and refractory diseases using AI based drug development platform in South Korea.

Cinclus Pharma Holding

Market Cap: SEK 746.5m

A clinical-stage pharmaceutical company, develops small molecules for the treatment of gastric acid-related diseases in China.

genedrive

Market Cap: UK£1.5m

Engages in the design, development, and manufacture of molecular diagnostics testing equipment for use in genotyping, pathogen detection, infectious disease detection, and other clinical indications.

CRISM Therapeutics

Market Cap: UK£3.8m

Develops a drug delivery technology for the clinical performance of cancer treatments for solid tumors through the local delivery of chemotherapy drugs.

Biosergen

Market Cap: SEK 123.5m

A biotech company, develops antifungal products.

ZhuZhou QianJin PharmaceuticalLtd

Market Cap: CN¥4.3b

Researches, produces, and sells Chinese patent medicines, chemical medicines, and feminine hygiene products in China.

Pharming Group

Market Cap: €770.8m

A biopharmaceutical company, develops and commercializes protein replacement therapies and precision medicines for the treatment of rare diseases in the United States, Europe, and internationally.

NurExone Biologic

Market Cap: CA$83.2m

A pharmaceutical technology company, develops a platform for biologically guided exosome-based therapies for the treatment of central nervous system injuries.

4basebio

Market Cap: UK£112.2m

Engages in the research, development, manufacturing, and commercialization of synthetic DNA and RNA products, and non-viral vector solutions in Europe, the United States, and internationally.

Nuvectis Pharma

Market Cap: US$151.5m

A clinical-stage biopharmaceutical company, focuses on the development of precision medicines for the treatment of serious conditions of unmet medical need in oncology.

Monte Rosa Therapeutics

Market Cap: US$404.5m

A clinical-stage biotechnology company, engages in the development of novel small molecule precision medicines that employ the body’s natural mechanisms to selectively degrade therapeutically relevant proteins.

Covalon Technologies

Market Cap: CA$58.9m

Engages in the research, development, manufacturing, and marketing of medical products in infection management, advanced wound care, and surgical procedure areas in the United States, Canada, the Middle East, Asia, Latin America, and internationally.

Philogen

Market Cap: €951.8m

A biotechnology company, develops drugs for oncology and chronic inflammatory diseases in Switzerland and the European Union.

CureVac

Market Cap: US$1.2b

A biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA).

OptiBiotix Health

Market Cap: UK£11.1m

A life sciences company, engages in the discovery and development of microbiome modulation products in the United Kingdom, the United States, India, China, and internationally.

Gyre Therapeutics

Market Cap: US$662.1m

A pharmaceutical company, engages in the development and commercialization of small-molecule, anti-inflammatory, and anti-fibrotic drugs targeting organ fibrosis.

Xenetic Biosciences

Market Cap: US$5.0m

A biopharmaceutical company, focuses on advancing immune-oncology technologies to treat cancers.

Gen Ilac Ve Saglik Urunleri Sanayi Ve Ticaret Anonim Sirketi

Market Cap: ₺52.7b

A pharmaceutical company, manufactures and supplies products to treat rare diseases and disorders worldwide.

Pharmala Biotech Holdings

Market Cap: CA$12.8m

Pharmala Biotech Holdings Inc., doing business as PharmAla, a biotechnology company, engages in the development, manufacture, and sale of MDMA and MDXX class molecules in service to the burgeoning clinical research community.

Relay Therapeutics

Market Cap: US$755.2m

Operates as a clinical-stage precision medicines company.

Organigram Global

Market Cap: CA$326.4m

Engages in the production and sale of cannabis and cannabis-derived products in Canada.